COM:SUPERNUS
Supernus Pharmaceuticals
- Stock
Last Close
35.82
22/11 21:00
Market Cap
2.00B
Beta: -
Volume Today
208.17K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '13 | Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
net income | -92.27M - | 19.87M 121.54% | 14.02M 29.47% | 91.22M 550.83% | 57.28M 37.20% | 110.99M 93.76% | 113.06M 1.86% | 126.95M 12.29% | 53.42M 57.92% | 60.71M 13.64% | 1.32M 97.83% | |
depreciation and amortization | 742K - | 928K 25.07% | 921K 0.75% | 2.40M 160.48% | 8.13M 238.97% | 7.06M 13.15% | 6.66M 5.72% | 18.14M 172.43% | 32.59M 79.68% | 85.54M 162.44% | 84.86M 0.80% | |
deferred income tax | 22.96M - | -371K 101.62% | 2.15M 678.17% | -41.79M 2,048.11% | 21.22M 150.79% | -4.17M 119.63% | -5.83M 39.96% | 568K 109.74% | -4.99M 979.23% | -26.32M 427.11% | -25.71M 2.32% | |
stock based compensation | 1.91M - | 2.72M 41.98% | 4.23M 55.78% | 5.93M 40.06% | 8.43M 42.31% | 11.29M 33.89% | 14.85M 31.49% | 16.56M 11.55% | 17.91M 8.15% | 17.57M 1.91% | 26.76M 52.32% | |
change in working capital | 5.67M - | -17.50M 408.39% | 10.06M 157.49% | 8.45M 16.04% | 23.71M 180.66% | -4.73M 119.97% | 613K 112.95% | -36.52M 6,056.77% | 3.57M 109.78% | -24.24M 779.08% | -9.14M 62.31% | |
accounts receivables | -5.04M - | -12.22M 142.24% | -8.64M 29.29% | -15.62M 80.82% | -24.06M 54.04% | -35.86M 49.03% | 15.75M 143.93% | -34.61M 319.71% | 3.87M 111.17% | -16.37M 523.22% | 18.77M 214.66% | |
inventory | -6M - | -6.29M 4.82% | 854K 113.58% | -4.21M 593.44% | 497K 111.79% | -9.36M 1,982.29% | -969K 89.64% | -10.12M 944.79% | -14.58M 44.01% | -17.86M 22.48% | 6.11M 134.21% | |
accounts payables | 8.49M - | -1.28M 115.06% | 2.06M 261.14% | 3.47M 68.36% | -620K 117.87% | -3.58M 477.10% | 6.96M 294.58% | 8.27M 18.82% | 18.18M 119.77% | -19.16M 205.41% | -36.29M 89.36% | |
other working capital | 8.23M - | 2.28M 72.25% | 15.79M 591.41% | 24.81M 57.18% | 47.89M 93.03% | 44.05M 8.01% | -21.13M 147.97% | -56K 99.73% | -3.90M 6,857.14% | 29.14M 848.05% | 2.27M 92.19% | |
other non cash items | 3.03M - | 2.09M 31.09% | 748K 64.21% | 605K 19.12% | -4.14M 784.79% | 8.54M 306.13% | 13.79M 61.44% | 12.69M 7.93% | 24.62M 93.97% | 3.57M 85.50% | 33.00M 824.17% | |
net cash provided by operating activities | -57.95M - | 7.73M 113.34% | 32.12M 315.40% | 66.81M 107.99% | 114.64M 71.59% | 128.99M 12.51% | 143.13M 10.96% | 138.40M 3.30% | 127.13M 8.14% | 116.83M 8.10% | 111.08M 4.91% | |
investments in property plant and equipment | -2.35M - | -593K 74.78% | -2.10M 254.81% | -1.60M 23.81% | -2.03M 26.58% | -844K 58.40% | -2.74M 224.17% | -3.45M 26.06% | -2.04M 40.71% | -412K 79.85% | -551K 33.74% | |
acquisitions net | 705K - | -313.54M - | -311.69M 0.59% | -14K 100.00% | ||||||||
purchases of investments | -85.57M - | -53.26M 37.75% | -63.20M 18.67% | -47.36M 25.06% | -101.89M 115.12% | -491.65M 382.54% | -409.71M 16.67% | -95.89M 76.60% | -311.57M 224.93% | -406.99M 30.62% | -101.62M 75.03% | |
sales maturities of investments | 75.81M - | 53.47M 29.46% | 37.58M 29.72% | 31.82M 15.32% | 28.66M 9.95% | 79.83M 178.56% | 253.17M 217.15% | 378.42M 49.47% | 530.51M 40.19% | 190.74M 64.05% | 370.90M 94.45% | |
other investing activites | -705K - | -4.50M 539.01% | -8.51M 88.81% | -18.82M 121.27% | -11.15M 40.74% | -809K 92.75% | 1.35M 266.75% | -241K 117.87% | 12.89M 5,447.72% | 14K 99.89% | ||
net cash used for investing activites | -12.11M - | -4.89M 59.65% | -36.23M 641.44% | -35.96M 0.75% | -86.42M 140.28% | -413.48M 378.48% | -157.92M 61.81% | -34.70M 78.03% | -81.91M 136.07% | -216.66M 164.50% | 268.73M 224.03% | |
debt repayment | -24.34M - | -802K - | -138.31M 17,146.26% | -402.50M - | ||||||||
common stock issued | 2.44M - | 571K 76.57% | 1.87M 226.97% | 2.05M 9.91% | 5.68M 176.85% | 11.58M 103.87% | 3.93M 66.09% | 4.36M 11.02% | 7.09M 62.69% | 12.42M 75.10% | 6.61M 46.79% | |
common stock repurchased | ||||||||||||
dividends paid | ||||||||||||
other financing activites | 84.65M - | -1K 100.00% | 364.86M - | 3.93M 98.92% | 3.56M 9.39% | 800K 77.52% | -22.90M 2,962.50% | -1.99M 91.31% | ||||
net cash used provided by financing activities | 62.74M - | 570K 99.09% | 1.87M 227.54% | 2.05M 9.91% | 5.68M 176.85% | 376.44M 6,526.26% | 3.93M 98.96% | 3.56M 9.39% | -130.42M 3,764.51% | -10.48M 91.97% | -397.88M 3,697.65% | |
effect of forex changes on cash | ||||||||||||
net change in cash | -7.32M - | 3.42M 146.65% | -2.24M 165.69% | 32.90M 1,566.13% | 33.91M 3.06% | 91.94M 171.17% | -10.87M 111.82% | 107.26M 1,087.02% | -85.21M 179.44% | -110.31M 29.47% | -18.07M 83.62% | |
cash at beginning of period | 40.30M - | 32.98M 18.17% | 36.40M 10.36% | 33.50M 7.96% | 66.40M 98.21% | 100.30M 51.06% | 192.25M 91.67% | 181.38M 5.65% | 288.64M 59.13% | 203.43M 29.52% | 93.12M 54.23% | |
cash at end of period | 32.98M - | 36.40M 10.36% | 34.15M 6.17% | 66.40M 94.42% | 100.30M 51.06% | 192.25M 91.67% | 181.38M 5.65% | 288.64M 59.13% | 203.43M 29.52% | 93.12M 54.23% | 75.05M 19.40% | |
operating cash flow | -57.95M - | 7.73M 113.34% | 32.12M 315.40% | 66.81M 107.99% | 114.64M 71.59% | 128.99M 12.51% | 143.13M 10.96% | 138.40M 3.30% | 127.13M 8.14% | 116.83M 8.10% | 111.08M 4.91% | |
capital expenditure | -2.35M - | -593K 74.78% | -2.10M 254.81% | -1.60M 23.81% | -2.03M 26.58% | -844K 58.40% | -2.74M 224.17% | -3.45M 26.06% | -2.04M 40.71% | -412K 79.85% | -551K 33.74% | |
free cash flow | -60.30M - | 7.14M 111.84% | 30.02M 320.43% | 65.21M 117.23% | 112.61M 72.69% | 128.14M 13.79% | 140.39M 9.56% | 134.95M 3.88% | 125.08M 7.31% | 116.41M 6.93% | 110.53M 5.05% |
All numbers in (except ratios and percentages)